The cardiovascular data technology developer has launched with $54m in funding, $43m coming from a Cigna Ventures-backed series B round.

Cleerly, a US-based developer of machine learning algorithms for heart disease detection, received $43m yesterday in a series B round featuring Cigna Ventures, the corporate venturing arm of healthcare services provider Cigna. The round was led by venture capital firm Vensana Capital and included LRVHealth, New Leaf Venture Partners, DigiTx Partners and American College of…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.